For Animal Treatment Only.

Do not vaccinate unhealthy animals.

It is recommended to vaccinate all horses on the premises according to the recommended schedule.

Maternally derived antibodies (MDA) can interfere with the development of active immunity. Please refer to section 8 for advice on vaccination in the presence of MDA.

Duvaxyn IE Plus is safe for use in pregnant mares in the second and third trimester, which have been vaccinated against influenza before pregnancy.

Avoid stress in the animals around the time of vaccination.

No information is available on the safety and efficacy of the concurrent use of this vaccine with any other except Duvaxyn EHV 1,4 and Duvaxyn T. It is therefore recommended that no other vaccines than these should be administered within 14 days before or after vaccination with the product.

Do not mix with any other medicinal product.

Withdrawal period: Zero days.

The occurence of adverse reactions after the first and second doses is low. After the third and subsequent doses, the incidence of adverse reactions, particularly local reactions, increases. Very commonly these reactions include visible swellings measuring less than 5 cm in diameter lasting for up to 1 day and mild, transient hyperthermia lasting up to 4 days. Common reactions include palpable, transient swellings and visible swellings measuring more than 5 cm in diameter which resolve within weeks and stiffness of the neck evident at between 2 to 4 days after vaccination. In rare occasions, abscessation may be observed. No information on microscopic features of the injection site reactions is available.

Hypersensitivity reactions to the vaccine may occur. In the event of an allergic reaction, immediate treatment should be given with a soluble glucocorticoid intravenously (e.g. dexamethasone sodium phosphate), adrenaline intramuscularly or antihistamine intramuscularly.

If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary practitioner.

In the case of accidental self-injection/ingestion/spillage onto skin, seek medical advice immediately and show the package insert or label to the physician.